Drugs & 
Pill 
Interaction 
Side 
Conditions 
Treatment 
Compare 
My Med 
Discount 
FDA 
Price 
Phonetic 
Health Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
FDA Grants Accelerated Approval for Imdelltra (tarlatamab-dlle) for the Treatment of Extensive-Stage Small Cell Lung Cancer
Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Imdelltra™ (tarlatamab-dlle) for the treatment...
Bristol Myers Squibb’s CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular Lymphoma
(BUSINESS WIRE) May 15, 2024 -- Bristol Myers Squibb (NYSE: BMY) today announced the U.S. Food and Drug Administration (FDA) has granted accelerated approval...
Baxter Secures FDA Approval of Clinolipid (Lipid Injectable Emulsion) Neonatal and Pediatric Indication
Baxter International Inc. (NYSE:BAX), a global leader in nutrition therapy, today announced U.S. FDA approval of an expanded indication for Clinolipid...
FDA Approves New Drug for Deadly Lung Cancer
The U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly lung cancer. Importantly, tarlatamab...
U.S. Justice Department Moves to Reclassify Weed as Less Risky Drug
The U.S. Justice Department on Thursday moved to reclassify marijuana as a less dangerous drug, setting the stage for a significant shift in the nation's...
Global Life Expectancy Could Rise By More Than 4 Years by 2050
Life expectancy around the world is expected to increase by nearly 5 years in men and more than 4 years in women during the next three decades, researchers...
Most Cancer Treatments Near End of Life Are Useless: Study
Cutting-edge cancer treatments are essentially useless for patients barely clinging to life, a new study shows.Chemotherapies, immunotherapies, targeted...
SUPERNOVA Phase III trial of Sipavibart Long-Acting Antibody Met Primary Endpoints in Preventing COVID-19 in Immunocompromised Patient Population
Positive high-level results from the SUPERNOVA Phase III COVID-19 pre-exposure prophylaxis (prevention) trial showed AstraZeneca’s sipavibart (formerly...
Elinzanetant Significantly Reduces Frequency and Severity of Moderate to Severe Hot Flashes Associated with Menopause
Berlin, May 16, 2024 – Bayer will present detailed results from the pivotal Phase III studies OASIS 1 and 2, showing that the investigational compound...
Web-Based Self-Help Intervention Beneficial for Binge Eating Disorder
For patients with binge eating disorder (BED), a web-based cognitive behavioral self-help intervention leads to significant reductions in binge eating...
2015 to 2021 Saw Increase in Electronic Vaping Product Use in Teens
From 2015 to 2021, there were significant increases in the use of electronic vapor products (EVPs) among adolescents, according to a study published in...
Semaglutide Reduces Need for Diuretics in Heart Failure
Semaglutide reduces the need for loop diuretics and has positive effects on symptoms, physical limitations, and body weight in patients with heart failure...
Slight Decline Seen in U.S. Drug Overdose Deaths
New 2023 provisional data from the National Center for Health Statistics show the first decline in deaths from drug overdose in the United States since...
Plant-Based Diets Tied to Long-Term Health Benefits
Plant-based diets appear beneficial in lowering cardiometabolic risk factors, as well as cardiovascular diseases (CVDs), cancer risk, and mortality, according...
Ascendis Pharma Announces Extension of U.S. Food and Drug Administration Review Period for TransCon PTH for Adults with Hypoparathyroidism
Ascendis Pharma A/S (Nasdaq: ASND) today announced that the U.S. Food and Drug Administration (FDA) notified the Company that information submitted in...
FDA Safety Communication: Do Not Use Cue Health’s COVID-19 Tests Due to Risk of False Results
The U.S. Food and Drug Administration (FDA) is warning home test users, caregivers, and health care providers not to use Cue Health’s COVID-19 Tests...
Lesbian, Bisexual Women More Likely to Die Early Than Straight Peers
Could being a lesbian or bisexual shorten your life? New research that analyzed decades of data on women suggests it might. What's driving the trend?...
Recently Added
Recently added consumer and prescribing information: Myhibbin, Rezenopy, Libervant, Beqvez, Xolremdi, Pivya, Xromi, Risvan, Voydeya, Winrevair
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex Carenotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Imdelltra Imdelltra (tarlatamab-dlle) is a first-in-class, bispecific delta-like ligand 3 (DLL3)-directed CD3 T cell engager indicated for the...
- Myhibbin Myhibbin (mycophenolate mofetil) is an antimetabolite immunosuppressant used for the prophylaxis of organ rejection.
- Libervant Libervant (diazepam) is a buccal film formulation of the benzodiazepine diazepam that may be given to treat children aged 2 to 5 years with...
Drugs in Development (Not yet approved)
- Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...
Drug Information
Tools
- Interaction Checker
- Pill Identifier
- Symptom Checker
- Medication Record
- Mobile Apps
- Drug Imprint Codes
- Community Support
- Compare Drugs
News & Alerts
- Medical News
- Clinical Trial Results
- FDA Drug Alerts
- FDA Consumer Updates
- New FDA Approvals
- New Drug Applications
- Drug Shortages
- Video Center
- Popular Articles
Professionals
Top 100 Drugs
- Abilify
- Acetaminophen
- Adderall
- Alprazolam
- Ambien
- Amitriptyline
- Amlodipine
- Amoxicillin
- Ativan
- Atorvastatin
- Avastin
- Azithromycin
- Baclofen
- Benadryl
- Benzonatate
- Biktarvy
- Botox
- Buprenorphine
- Bupropion
- Buspirone
- Cephalexin
- Cetirizine
- Ciprofloxacin
- Citalopram
- Clindamycin
- Clonazepam
- Clonidine
- Cyclobenzaprine
- Cymbalta
- Dexamethasone
- Diazepam
- Diclofenac
- Doxycycline
- Duloxetine
- Dupixent
- Eliquis
- Entyvio
- Epclusa
- Ezetimibe
- Famotidine
- Farxiga
- Fluoxetine
- Furosemide
- Gabapentin
- Humira
- Hydrochlorothiazide
- Hydrocodone
- Hydroxyzine
- Ibuprofen
- Januvia
- Jardiance
- Keytruda
- Klonopin
- Levothyroxine
- Lexapro
- Lisinopril
- Loratadine
- Lorazepam
- Losartan
- Lyrica
- Meloxicam
- Metformin
- Methadone
- Methylprednisolone
- Methocarbamol
- Methotrexate
- Metoprolol
- Metronidazole
- Miralax
- Mirtazapine
- Montelukast
- Mounjaro
- Mucinex
- Naloxone
- Naltrexone
- Naproxen
- Nitrofurantoin
- Omeprazole
- Opdivo
- Ondansetron
- Otezla
- Oxycodone
- Ozempic
- Pantoprazole
- Paxlovid
- Penicillin
- Percocet
- Phentermine
- Plan B
- Praluent
- Prednisone
- Promethazine
- Propranolol
- Prozac
- Qulipta
- Repatha
- Restasis
- Rexulti
- Semaglutide
- Seroquel
- Sertraline
- Sildenafil
- Skyrizi
- Soma
- Spironolactone
- Stelara
- Sublocade
- Suboxone
- Taltz
- Tamsulosin
- Tizanidine
- Toradol
- Tramadol
- Trazodone
- Trintellix
- Tylenol
- Ubrelvy
- Valium
- Venlafaxine
- Verzenio
- Viagra
- Vraylar
- Vyvanse
- Wegovy
- Wellbutrin
- Xanax
- Xolair
- Zofran
- Zoloft
- Zyrtec
